Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-09-19
2006-09-19
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07109167
ABSTRACT:
The present invention provides compounds for targeting endothelial cells, tumor cells or other cells that express the NP-1 receptor, compositions containing the same and methods for their use. Additionally, the present invention includes diagnostic, therapeutic and radiotherapeutic compositions useful for visualization, therapy or radiotherapy.
REFERENCES:
patent: 5659041 (1997-08-01), Pollak et al.
patent: 5789555 (1998-08-01), Pollak
patent: 5821330 (1998-10-01), Itaya
patent: 5855866 (1999-01-01), Thorpe et al.
patent: 6051230 (2000-04-01), Thorpe et al.
patent: 6252664 (2001-06-01), Barbera-Guillem
patent: 6261535 (2001-07-01), Thorpe et al.
patent: 6261537 (2001-07-01), Klaveness et al.
patent: 6264917 (2001-07-01), Klaveness et al.
patent: 6333110 (2001-12-01), Barbera-Guillem
patent: 6521211 (2003-02-01), Unger et al.
patent: 6777534 (2004-08-01), Klagsbrun et al.
patent: 6800273 (2004-10-01), Rajopadhye et al.
patent: 2002/0001566 (2002-01-01), Rajopadhye
patent: 2003/0082103 (2003-05-01), Wartchow et al.
patent: 2003/0133972 (2003-07-01), Danthi et al.
patent: 0649857 (1995-04-01), None
patent: WO 94/10202 (1994-05-01), None
patent: WO 96/40285 (1996-12-01), None
patent: WO 98/18498 (1998-05-01), None
patent: WO 98/18500 (1998-05-01), None
patent: WO 98/18501 (1998-05-01), None
patent: WO 98/47541 (1998-10-01), None
patent: WO 98/53857 (1998-12-01), None
patent: WO 99/13919 (1999-03-01), None
patent: WO 99/20312 (1999-04-01), None
patent: WO 99/29861 (1999-06-01), None
patent: WO 99/40947 (1999-08-01), None
patent: WO 99/58162 (1999-11-01), None
patent: WO 01/42284 (2001-06-01), None
patent: WO 01/54723 (2001-08-01), None
patent: WO 01/62942 (2001-08-01), None
patent: WO 01/70945 (2001-09-01), None
patent: WO 01/83693 (2001-11-01), None
patent: WO 01/97850 (2001-12-01), None
patent: WO 01/98294 (2001-12-01), None
patent: WO 02/07747 (2002-01-01), None
patent: WO 03/028643 (2003-04-01), None
patent: WO 03/029814 (2003-04-01), None
patent: WO 03/092737 (2003-11-01), None
patent: WO 03/094617 (2003-11-01), None
patent: WO 03/103581 (2003-12-01), None
Online-Medical Dictionary. “Amino acid”. http://cancerweb.ncl.ac.uk/cgi-bin/omd?query=amino+acid. Nov. 13, 1997.
Online-Medical Dictionary. “Analogue”. http://cancerweb.ncl.ac.uk/cgi-bin/omd?analogue. Jan. 10, 1998.
R. Dunn-Dufault, et al, Convenient Preparation of No-Carrier-Added-Technetium-99m Radiopharmaceuticals Using Solid-Phase Technology, 1999, pp. 832-837, vol. 10, XP002200847 Washington US; abstract; figures 1,2.
Linder Karen
Marinelli Edmund R.
Nanjappan Palaniappa
Nunn Adrian D.
Pillai Radhakrishna
Audet Maury
Bracco International B.V.
Kramer Levin Naftalis & Frankel LLP
Tate Christopher R.
LandOfFree
Compounds for targeting endothelial cells, compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for targeting endothelial cells, compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for targeting endothelial cells, compositions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3550533